Skip to main content
Livermore
Livermore
ZHEN

Eiger BioPharmaceuticals, Inc.

EIGRDelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001305253

Eiger BioPharmaceuticals, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 43 institutions reported holding it in 13F filings for Q4 2023, worth $4.16M in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Eiger BioPharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

EIGR is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.

Institutional holders
43
−8 vs. Q3 2023
Shares held
18.6M
−1.39M (−7.0%) vs. Q3 2023
Total value
$4.16M
−$1.92M (−31.6%) vs. Q3 2023
New holders
5
7 more added
Sold out
13
16 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting EIGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 43 institutions
Q1 2021: 94 institutionsQ2 2021: 90 institutionsQ3 2021: 92 institutionsQ4 2021: 86 institutionsQ1 2022: 95 institutionsQ2 2022: 91 institutionsQ3 2022: 92 institutionsQ4 2022: 81 institutionsQ1 2023: 71 institutionsQ2 2023: 67 institutionsQ3 2023: 51 institutionsQ4 2023: 43 institutionsQ1 2024: 24 institutionsQ2 2024: 2 institutionsQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $4.16M
Q1 2021: $207.5MQ2 2021: $196.3MQ3 2021: $151.0MQ4 2021: $124.1MQ1 2022: $252.0MQ2 2022: $187.8MQ3 2022: $225.3MQ4 2022: $29.6MQ1 2023: $22.2MQ2 2023: $14.6MQ3 2023: $6.08MQ4 2023: $4.16MQ1 2024: $3.19MQ2 2024: $1.85MQ3 2024: $1.24MQ4 2024: $765.0KQ1 2025: $423.0KQ2 2025: $423.0KQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding EIGR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20251$423.0K
Q1 20251$423.0K
Q4 20241$765.0K
Q3 20241$1.24M
Q2 20242$1.85M
Q1 202424$3.19M
Q4 202343$4.16M
Q3 202351$6.08M
Q2 202367$14.6M
Q1 202371$22.2M
Q4 202281$29.6M
Q3 202292$225.3M
Q2 202291$187.8M
Q1 202295$252.0M
Q4 202186$124.1M
Q3 202192$151.0M
Q2 202190$196.3M
Q1 202194$207.5M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Eiger BioPharmaceuticals, Inc.; share changes are against Q3 2023.

Institutions holding EIGR in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada1,362$00.00%+424+45.2%Added
Cutler Group LP1,000$00.00%00.0%Unchanged
JPMorgan Chase & Co166$370.00%−8,242−98.0%Reduced
Perkins Coie Trust Co178$390.00%00.0%Unchanged
Wells Fargo & Company307$690.00%−19,983−98.5%Reduced
Federation des caisses Desjardins du Quebec370$830.00%00.0%Unchanged
Sound Income Strategies, LLC400$900.00%00.0%Unchanged
National Bank of Canada1,280$3010.00%00.0%Unchanged
Rhumbline Advisers2,320$5220.00%00.0%Unchanged
BNP Paribas Arbitrage, SA2,904$6520.00%−19−0.7%Reduced
Citigroup Inc2,944$6610.00%−793−21.2%Reduced
Advisor Group Holdings, Inc.7,750$1.85K0.00%−14,650−65.4%Reduced
Simplex Trading, LLC13,095$2.00K0.00%+913+7.5%Added
Citadel Advisors LLC10,008$2.25K0.00%+10,008New
UBS Group AG11,045$2.48K0.00%+10,988+19,277.2%Added
Prudential Financial Inc12,000$2.69K0.00%+12,000New
Morgan Stanley13,812$3.10K0.00%−15,686−53.2%Reduced
Engineers Gate Manager LP14,478$3.25K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)18,278$4.11K0.00%+1,785+10.8%Added
Bank of New York Mellon Corp20,640$4.63K0.00%00.0%Unchanged
Susquehanna International Group, LLP25,513$5.73K0.00%+3,818+17.6%Added
HRT Financial LP29,118$6.00K0.00%+29,118New
Jane Street Group, LLC29,505$6.62K0.00%+14,775+100.3%Added
TownSquare Capital, LLC32,430$7.28K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc33,436$7.51K0.00%00.0%Unchanged
DFPG Investments, LLC32,430$7.98K0.00%00.0%Unchanged
Tocqueville Asset Management L.P.37,325$8.38K0.00%−13,750−26.9%Reduced
Bank of America Corp48,121$10.8K0.00%−2,201−4.4%Reduced
Verition Fund Management LLC54,182$12.2K0.00%−8,300−13.3%Reduced
Two Sigma Securities, LLC57,221$12.8K0.00%+21,431+59.9%Added
Sequoia Financial Advisors, LLC63,000$14.1K0.00%00.0%Unchanged
Millennium Management LLC81,144$18.2K0.00%−188,149−69.9%Reduced
Northern Trust Corp112,323$25.2K0.00%00.0%Unchanged
State Street Corp146,781$33.0K0.00%00.0%Unchanged
Acadian Asset Management LLC174,088$38.0K0.00%−63,946−26.9%Reduced
RBF Capital, LLC338,733$76.0K0.00%−52,532−13.4%Reduced
Renaissance Technologies LLC344,210$77.0K0.00%+344,210New
Geode Capital Management, LLC379,707$85.3K0.00%00.0%Unchanged
BlackRock Inc.583,730$131.0K0.00%−302,404−34.1%Reduced
Vanguard Group Inc1,820,767$408.8K0.00%−143,535−7.3%Reduced
683 Capital Management, LLC2,100,000$471.4K0.05%−550,000−20.8%Reduced
Propel Bio Management, LLC4,391,432$985.9K0.82%+4,391,432New
Ameriprise Financial Inc7,505,539$1.68M0.00%−1,086,932−12.6%Reduced
Simplify Asset Management Inc.0$00.00%−2,700,000−100.0%Sold out
UBS Oconnor LLC0$00.00%−393,975−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−355,867−100.0%Sold out
DRW Securities, LLC0$00.00%−120,365−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−106,700−100.0%Sold out
Sigma Planning Corp0$00.00%−41,500−100.0%Sold out
Two Sigma Investments, LP0$00.00%−17,900−100.0%Sold out
XTX Topco Ltd0$00.00%−15,597−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−6,091−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−1,133−100.0%Sold out
Toth Financial Advisory Corp0$00.00%−335−100.0%Sold out
Federated Hermes, Inc.0$00.00%−92−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−72−100.0%Sold out